Slide One
HYBRID 2021 START-UPS
Slide One
HYBRID 2021 START-UPS

HYBRID 2021:

CALL FOR

EXPRESSION

OF INTEREST

START-UPS IN IMMUNOLOGY AND INFLAMMATORY DISORDERS

A call for expression of interest dedicated to start-ups evolving in the field of immunology and inflammatory disorders is now open!
We are looking for start-ups working in the field of:

  • Check-points targets
  • Immunomodulation
  • Systemic auto-immune diseases (lupus, arthritis, vasculitis, scleroderma)
  • Organ-specific auto-immune diseases (inflammatory bowel diseases, neuro-inflammation)
  • Diagnostic tools
  • Microbiota (immunogenic bacteria)
  • Biomarkers
  • e-health solutions & AI based solutions (incl. devices)